Ivan Osokine | UCSF Profiles

Ivan Osokine, PhD, MD

Title	Postdoctoral Scholar
Institution	University of California San Francisco
Department	Laboratory Medicine
Phone	415-476-1114
vCard	Download vCard

Biography

Education and Training

University of California, Los Angeles	MD	2016	David Geffen School of Medicine
University of California, Los Angeles	PhD	2014	Microbiology, Immunology, and Molecular Genetics

Overview

I am a postdoctoral scholar in the lab of Adrian Erlebacher. I study how the interaction between maternal and fetal tissue promotes a tolerogenic immune state that permits the fetus to develop and avoid rejection by the maternal immune system.

Interests

I am interested in pursuing clinically relevant basic research into immunology, maternal/fetal tolerance, and regulation of lymphocyte activation, trafficking, and effector responses.

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Snell LM, MacLeod BL, Law JC, Osokine I, Elsaesser HJ, Hezaveh K, Dickson RJ, Gavin MA, Guidos CJ, McGaha TL, Brooks DG. CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity. Immunity. 2018 Oct 16; 49(4):678-694.e5. PMID: 30314757.

View in: PubMed
Nancy P, Siewiera J, Rizzuto G, Tagliani E, Osokine I, Manandhar P, Dolgalev I, Clementi C, Tsirigos A, Erlebacher A. H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest. 2018 Jan 02; 128(1):233-247. PMID: 29202469.

View in: PubMed
Osokine I, Erlebacher A. Inflammation and Autism: From Maternal Gut to Fetal Brain. Trends Mol Med. 2017 12; 23(12):1070-1071. PMID: 29122491.

View in: PubMed
Snell LM, Osokine I, Yamada DH, De la Fuente JR, Elsaesser HJ, Brooks DG. Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection. Cell Rep. 2016 09 20; 16(12):3286-3296. PMID: 27653690.

View in: PubMed
Osokine I, Snell LM, Cunningham CR, Yamada DH, Wilson EB, Elsaesser HJ, de la Torre JC, Brooks D. Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection. Proc Natl Acad Sci U S A. 2014 May 20; 111(20):7409-14. PMID: 24799699; PMCID: PMC4034239.

View in: PubMed, PubMed Central
Osokine I, Hsu R, Loeb GB, McManus MT. Unintentional miRNA ablation is a risk factor in gene knockout studies: a short report. PLoS Genet. 2008 Feb; 4(2):e34. PMID: 18282110; PMCID: PMC2242815.

View in: PubMed, PubMed Central